
Results
7
Stocks with a market cap under US$50M.
7 companies
Ascelia Pharma
Market Cap: SEK 438.0m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 0.81
7D
-73.8%
1Y
-82.0%
Sprint Bioscience
Market Cap: SEK 428.4m
A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.
SPRINT
SEK 4.07
7D
-8.5%
1Y
694.9%
Elicera Therapeutics
Market Cap: SEK 190.5m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 2.93
7D
12.7%
1Y
-46.2%
Subgen AI
Market Cap: SEK 71.3m
Develops artificial intelligence-based models and applications to control data for government and businesses.
SUBGEN
SEK 0.072
7D
53.4%
1Y
n/a
ODI Pharma
Market Cap: SEK 46.9m
A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.
ODI
SEK 2.24
7D
-12.5%
1Y
31.0%
Chosa Oncology
Market Cap: SEK 34.4m
Develops oncology drugs cisplatin for the treatment of cancer.
CHOSA
SEK 0.53
7D
0%
1Y
-59.2%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%